Newsroom
Sorted by: Latest
-
Fill Up Média booste la visibilité et le trafic des centres auto Feu Vert grâce à l’activation d’une campagne DOOH géolocalisée « drive-to-store »
LYON, France--(BUSINESS WIRE)--Regulatory News : Fill Up Média (Paris:ALFUM), leader français de l’affichage digital extérieur sonore sur distributeurs de carburant (code ISIN : FR001400AEM6 – mnémonique : ALFUM), présente les résultats d’une deuxième campagne publicitaire réalisée pendant deux semaines au bénéfice de l’annonceur Feu Vert, expert de l’entretien automobile. Feu Vert a déployé, en partenariat avec Fill Up Média, une campagne géolocalisée de type « drive-to-store » visant à renfo...
-
4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics
LILLE, France & PARIS--(BUSINESS WIRE)--4Moving Biotech Receives FDA IND Clearance for 4P004...
-
AFYREN annonce le versement de financements complémentaires de 7 millions d’euros pour sa filiale AFYREN NEOXY
CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News : AFYREN (Paris:ALAFY), société de greentech qui offre aux industriels des produits biosourcés et bas-carbone grâce à sa technologie de fermentation unique basée sur un modèle complètement circulaire annonce le versement d’un financement total de 7 millions d’euros pour le compte de sa filiale AFYREN NEOXY, via le déblocage des deuxièmes tranches du prêt «Sustainability-linked» obtenu en Décembre 2024 et du Prêt Nouvelle...
-
AFYREN Confirms Drawdown of €7 Million in Previously Secured Financing for its Subsidiary AFYREN NEOXY
CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, announces it has received €7 million in additional financing for its subsidiary AFYREN NEOXY. This was obtained through the release of the second tranche of the Sustainability-linked loan secured in December 2024 and the New Industry Loan obtained in Novembe...
-
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon enters into agreement to expand access to a new, first-in-class treatment in certain European countries; builds on cardiovascular portfolio...
-
Exponents’ Tiki Bar–Themed Booth Wins Bronze at the Experience Design Awards
ORLANDO, Fla.--(BUSINESS WIRE)--What started as a tiki bar idea turned into an award-winning showstopper. At SOT 2025, a premier event for the life sciences and clinical research community, Exponents Insta USA Inc. partnered with Altasciences to create a booth that would stand apart on a crowded, highly technical show floor. Rather than leaning on screens or complex technology, the brand envisioned a tropical escape that felt welcoming, memorable, and human. Team Exponents brought that vision t...
-
Pacific Prime Dubai Was Awarded AXA/Daman Market Excellence Award
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Pacific Prime Dubai, a global health insurance broker, risk specialist, and benefits specialist, concluded the year 2025 strongly with the AXA Global Healthcare/Daman Market Excellence Award. The award was presented by Karim Idilby, Chief Growth Officer of AXA/Daman, at the Pacific Prime Dubai office on 10 December 2025, with Pierre de Mirman, Global Managing Director; Michael Lavelle, Head of Individual Sales; Mark McClelland, Director of Commercia...
-
Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference
LEIDEN, Netherlands--(BUSINESS WIRE)--Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that it will present at J.P. Morgan’s 44th Annual Healthcare Conference on Thursday, January 15. The company’s presentation will begin at 9:30 am PT/12:30 am ET/6:30 am CET. The presentation will focus on the company’s lead product, nizubaglustat, a potential treatment for rare lysosomal storage disord...
-
Antin to Acquire Emsere, a Global Leader in Clinical Trial Equipment Infrastructure
PARIS & LONDON & NEW YORK--(BUSINESS WIRE)--Regulatory News: Antin Infrastructure Partners (Paris:ANTIN) has agreed with Dutch family office and investment platform Gryphion to acquire Emsere, a leading medical equipment rental specialist, providing mission-critical medical equipment and service solutions, including specialised logistics for clinical trials globally. The investment will be made by Antin’s Mid Cap Fund I. Headquartered in Leiden, the Netherlands, Emsere provides contract researc...
-
Prodapt Earns ISO 42001 Certification, the New Global Benchmark for Responsible Enterprise AI
CHENNAI, India--(BUSINESS WIRE)--Prodapt has been awarded the ISO 42001 certification, the world’s first and the only global standard for AI Management Systems (AIMS)....